Glutathione-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.
To investigate the effects of the predominant nonprotein thiol, glutathione (GSH), on redox homeostasis, we employed complementary pharmacological and genetic strategies to determine the consequences of both loss- and gain-of-function GSH content in vitro. We monitored the redox events in the cytosol and mitochondria using reduction-oxidation sensitive green fluorescent protein (roGFP) probes and the level of reduced/oxidized thioredoxins (Trxs). Either H(2)O(2) or the Trx reductase inhibitor 1-chloro-2,4-dinitrobenzene (DNCB), in embryonic rat heart (H9c2) cells, evoked 8 or 50 mV more oxidizing glutathione redox potential, E(hc) (GSSG/2GSH), respectively. In contrast, N-acetyl-L-cysteine (NAC) treatment in H9c2 cells, or overexpression of either the glutamate cysteine ligase (GCL) catalytic subunit (GCLC) or GCL modifier subunit (GCLM) in human embryonic kidney 293 T (HEK293T) cells, led to 3- to 4-fold increase of GSH and caused 7 or 12 mV more reducing E(hc), respectively. This condition paradoxically increased the level of mitochondrial oxidation, as demonstrated by redox shifts in mitochondrial roGFP and Trx2. Lastly, either NAC treatment (EC(50) 4 mM) or either GCLC or GCLM overexpression exhibited increased cytotoxicity and the susceptibility to the more reducing milieu was achieved at decreased levels of ROS. Taken together, our findings reveal a novel mechanism by which GSH-dependent reductive stress triggers mitochondrial oxidation and cytotoxicity.
Laboratory of Cardiac Disease, Redox Signaling, and Cell Regeneration, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.
Huali
H
Zhang
Pattraranee
P
Limphong
Joel
J
Pieper
Qiang
Q
Liu
Christopher K
CK
Rodesch
Elisabeth
E
Christians
Ivor J
IJ
Benjamin
D000111:Acetylcysteine / Q000494:pharmacology; D000818:Animals; D003600:Cytosol / Q000378:metabolism; D004137:Dinitrochlorobenzene / Q000494:pharmacology; D016166:Free Radical Scavengers / Q000494:pharmacology; D005721:Glutamate-Cysteine Ligase / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism*; D019803:Glutathione Disulfide / Q000378:metabolism; D049452:Green Fluorescent Proteins / Q000737:chemistry / Q000378:metabolism; D057809:HEK293 Cells; D006321:Heart / Q000187:drug effects / Q000196:embryology; D006706:Homeostasis; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007202:Indicators and Reagents / Q000494:pharmacology; D008928:Mitochondria / Q000378:metabolism*; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D016877:Oxidants / Q000494:pharmacology; D010084:Oxidation-Reduction; D018384:Oxidative Stress; D021122:Protein Subunits / Q000378:metabolism; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D013879:Thioredoxins / Q000378:metabolism
D004137:Dinitrochlorobenzene; D016166:Free Radical Scavengers; D007202:Indicators and Reagents; D016877:Oxidants; D021122:Protein Subunits; D017382:Reactive Oxygen Species; D049452:Green Fluorescent Proteins; D013879:Thioredoxins; D006861:Hydrogen Peroxide; D005721:Glutamate-Cysteine Ligase; D005978:Glutathione; D019803:Glutathione Disulfide; D000111:Acetylcysteine